87 related articles for article (PubMed ID: 1290168)
1. Dibucaine elicits platelet procoagulant activity in factor VIII and factor X activation by a mechanism involving a sulfhydryl-dependent enzyme.
Hultin MB; Hennessey J; Morrison SA
Thromb Res; 1992 Dec; 68(4-5):399-407. PubMed ID: 1290168
[TBL] [Abstract][Full Text] [Related]
2. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets.
Fox JE; Austin CD; Reynolds CC; Steffen PK
J Biol Chem; 1991 Jul; 266(20):13289-95. PubMed ID: 2071604
[TBL] [Abstract][Full Text] [Related]
3. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry?
Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487
[TBL] [Abstract][Full Text] [Related]
4. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
5. Role of human factor VIII in factor X activation.
Hultin MB
J Clin Invest; 1982 Apr; 69(4):950-8. PubMed ID: 6804496
[TBL] [Abstract][Full Text] [Related]
6. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Ahmad SS; Walsh PN
Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
[TBL] [Abstract][Full Text] [Related]
7. Calpain activator dibucaine induces platelet apoptosis.
Zhang W; Liu J; Sun R; Zhao L; Du J; Ruan C; Dai K
Int J Mol Sci; 2011; 12(4):2125-37. PubMed ID: 21731431
[TBL] [Abstract][Full Text] [Related]
8. Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.
Ishii H; Kuboki M; Fujii J; Hiraishi S; Kazama M
Thromb Res; 1990 Mar; 57(6):847-61. PubMed ID: 2382255
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Rawala-Sheikh R; Ahmad SS; Ashby B; Walsh PN
Biochemistry; 1990 Mar; 29(10):2606-11. PubMed ID: 2110473
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII influences binding of factor IX and factor X to intact human platelets.
Muntean W; Leschnik B
Thromb Res; 1989 Sep; 55(5):537-48. PubMed ID: 2510357
[TBL] [Abstract][Full Text] [Related]
11. The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane.
Yano Y; Shiba E; Kambayashi J; Sakon M; Kawasaki T; Fujitani K; Kang J; Mori T
Thromb Res; 1993 Sep; 71(5):385-96. PubMed ID: 8236165
[TBL] [Abstract][Full Text] [Related]
12. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
13. Platelet procoagulant complex assembly in a tissue factor-initiated system.
Monroe DM; Roberts HR; Hoffman M
Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
[TBL] [Abstract][Full Text] [Related]
14. Effects of diamide and dibucaine on platelet glycoprotein Ib, actin-binding protein and cytoskeleton.
Solum NO; Olsen TM
Biochim Biophys Acta; 1985 Jul; 817(2):249-60. PubMed ID: 2990556
[TBL] [Abstract][Full Text] [Related]
15. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets.
Hultin MB
Blood; 1985 Jul; 66(1):53-8. PubMed ID: 3924141
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors.
Niewiarowski S; Kirby EP; Brudzynski TM; Stocker K
Biochemistry; 1979 Aug; 18(16):3570-7. PubMed ID: 476069
[TBL] [Abstract][Full Text] [Related]
18. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects.
Gwozdz AM; Leung R; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
Thromb Haemost; 2010 Jun; 103(6):1218-27. PubMed ID: 20352156
[TBL] [Abstract][Full Text] [Related]
19. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
Kempton CL; Hoffman M; Roberts HR; Monroe DM
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
[TBL] [Abstract][Full Text] [Related]
20. The action of calcium-dependent protease on platelet surface glycoproteins.
McGowan EB; Yeo KT; Detwiler TC
Arch Biochem Biophys; 1983 Nov; 227(1):287-301. PubMed ID: 6314909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
